901 related articles for article (PubMed ID: 12797957)
1. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.
Willie JT; Chemelli RM; Sinton CM; Tokita S; Williams SC; Kisanuki YY; Marcus JN; Lee C; Elmquist JK; Kohlmeier KA; Leonard CS; Richardson JA; Hammer RE; Yanagisawa M
Neuron; 2003 Jun; 38(5):715-30. PubMed ID: 12797957
[TBL] [Abstract][Full Text] [Related]
2. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.
Chemelli RM; Willie JT; Sinton CM; Elmquist JK; Scammell T; Lee C; Richardson JA; Williams SC; Xiong Y; Kisanuki Y; Fitch TE; Nakazato M; Hammer RE; Saper CB; Yanagisawa M
Cell; 1999 Aug; 98(4):437-51. PubMed ID: 10481909
[TBL] [Abstract][Full Text] [Related]
3. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat.
Beuckmann CT; Sinton CM; Williams SC; Richardson JA; Hammer RE; Sakurai T; Yanagisawa M
J Neurosci; 2004 May; 24(18):4469-77. PubMed ID: 15128861
[TBL] [Abstract][Full Text] [Related]
4. Behavioral state instability in orexin knock-out mice.
Mochizuki T; Crocker A; McCormack S; Yanagisawa M; Sakurai T; Scammell TE
J Neurosci; 2004 Jul; 24(28):6291-300. PubMed ID: 15254084
[TBL] [Abstract][Full Text] [Related]
5. Arousal effect of orexin A depends on activation of the histaminergic system.
Huang ZL; Qu WM; Li WD; Mochizuki T; Eguchi N; Watanabe T; Urade Y; Hayaishi O
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9965-70. PubMed ID: 11493714
[TBL] [Abstract][Full Text] [Related]
6. The hypocretin/orexin system in health and disease.
Nishino S
Biol Psychiatry; 2003 Jul; 54(2):87-95. PubMed ID: 12873797
[TBL] [Abstract][Full Text] [Related]
7. Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice.
Mochizuki T; Arrigoni E; Marcus JN; Clark EL; Yamamoto M; Honer M; Borroni E; Lowell BB; Elmquist JK; Scammell TE
Proc Natl Acad Sci U S A; 2011 Mar; 108(11):4471-6. PubMed ID: 21368172
[TBL] [Abstract][Full Text] [Related]
8. Narcolepsy: a key role for hypocretins (orexins).
Siegel JM
Cell; 1999 Aug; 98(4):409-12. PubMed ID: 10481905
[No Abstract] [Full Text] [Related]
9. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice.
Mieda M; Willie JT; Hara J; Sinton CM; Sakurai T; Yanagisawa M
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4649-54. PubMed ID: 15070772
[TBL] [Abstract][Full Text] [Related]
10. Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep.
Mieda M; Hasegawa E; Kisanuki YY; Sinton CM; Yanagisawa M; Sakurai T
J Neurosci; 2011 Apr; 31(17):6518-26. PubMed ID: 21525292
[TBL] [Abstract][Full Text] [Related]
11. Sleep, feeding, and neuropeptides: roles of orexins and orexin receptors.
Mieda M; Yanagisawa M
Curr Opin Neurobiol; 2002 Jun; 12(3):339-45. PubMed ID: 12049942
[TBL] [Abstract][Full Text] [Related]
12. Orexin (hypocretin) gene transfer diminishes narcoleptic sleep behavior in mice.
Liu M; Thankachan S; Kaur S; Begum S; Blanco-Centurion C; Sakurai T; Yanagisawa M; Neve R; Shiromani PJ
Eur J Neurosci; 2008 Oct; 28(7):1382-93. PubMed ID: 18973565
[TBL] [Abstract][Full Text] [Related]
13. Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models.
Irukayama-Tomobe Y; Ogawa Y; Tominaga H; Ishikawa Y; Hosokawa N; Ambai S; Kawabe Y; Uchida S; Nakajima R; Saitoh T; Kanda T; Vogt K; Sakurai T; Nagase H; Yanagisawa M
Proc Natl Acad Sci U S A; 2017 May; 114(22):5731-5736. PubMed ID: 28507129
[TBL] [Abstract][Full Text] [Related]
14. Orexin neurons suppress narcolepsy via 2 distinct efferent pathways.
Hasegawa E; Yanagisawa M; Sakurai T; Mieda M
J Clin Invest; 2014 Feb; 124(2):604-16. PubMed ID: 24382351
[TBL] [Abstract][Full Text] [Related]
15. Melanin-concentrating hormone neurons contribute to dysregulation of rapid eye movement sleep in narcolepsy.
Naganuma F; Bandaru SS; Absi G; Mahoney CE; Scammell TE; Vetrivelan R
Neurobiol Dis; 2018 Dec; 120():12-20. PubMed ID: 30149182
[TBL] [Abstract][Full Text] [Related]
16. Activity of pontine neurons during sleep and cataplexy in hypocretin knock-out mice.
Thankachan S; Kaur S; Shiromani PJ
J Neurosci; 2009 Feb; 29(5):1580-5. PubMed ID: 19193905
[TBL] [Abstract][Full Text] [Related]
17. Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy.
Dauvilliers Y; Jennum P; Plazzi G
Sleep Med; 2013 Aug; 14(8):775-81. PubMed ID: 23219054
[TBL] [Abstract][Full Text] [Related]
18. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
Hoyer D; Jacobson LH
Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
[TBL] [Abstract][Full Text] [Related]
19. Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates.
Willie JT; Renthal W; Chemelli RM; Miller MS; Scammell TE; Yanagisawa M; Sinton CM
Neuroscience; 2005; 130(4):983-95. PubMed ID: 15652995
[TBL] [Abstract][Full Text] [Related]
20. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]